Anti Diabetics
Generic Name: TENELIGLIPTIN
Description : Teneligliptin is a Novel Dipeptidyl Peptidase IV inhibitors for the treatment of type 2 diabetes with minimal risk of hypoglycemia and weight gain. TENeLIgliptin act on inCRETins with elevation of activated glucagon-like peptide 1 (GLP-1) levels and the resulting suppression of postprandial hyperglycemia.
Indications: As an adjunct to diet and exercise to improve glycemic control in adults with type 2 Diabetes mellitus.
Patient guidance: Patients with diabetes should be advised to inform their healthcare provider if they are pregnant, contemplating pregnancy, breastfeeding, or contemplating breastfeeding.
Storage: Store at 25° C (77° F)
| Strengths Available | Presentation | Brand Name |
| Teneligliptin 20 mg | 3 x 10 tablets | TENLICRET |
Generic Name: GLIMEPIRIDE IP
Description : Glimepiride primarily lowers blood glucose by stimulating the release of insulin from pancreatic beta cells. Sulfonylureas bind to the sulfonylurea receptor in the pancreatic beta-cell plasma membrane, leading to closure of the ATP-sensitive potassium channel, thereby stimulating the release of insulin.
Indications: As an adjunct to diet and exercise to improve glycemic control in adults with type 2 Diabetes mellitus.
Patient guidance: Patients with diabetes should be advised to inform their healthcare provider if they are pregnant, contemplating pregnancy, breastfeeding, or contemplating breastfeeding.
Storage: Store at 25° C (77° F)
| Strengths Available | Presentation | Brand Name |
| Glimepiride 1mg | 10 X 10 tablets | ZYVANA 1 |
| Glimepiride 2mg | 10 X 10 tablets | ZYVANA 2 |
Generic Name: GLIMEPIRIDE & METFORMIN HYDROCHLORIDE
Description : Glimepiride stimulates the insulin release from functioning pancreatic β-cells and inhibits gluconeogenesis at hepatic cells. It also increases insulin sensitivity at peripheral target sites. Metformin decreases hepatic gluconeogenesis, decreases intestinal absorption of glucose and improves insulin sensitivity (increases peripheral glucose uptake and utilisation).
Indications: In Type 2 Diabetes uncontrolled by mono therapy.
Patient guidance: Patients with diabetes should be advised to inform their healthcare provider if they are pregnant, contemplating pregnancy, breastfeeding, or contemplating breastfeeding.
Storage: Store at 25° C (77° F)
| Strengths Available | Presentation | Brand Name |
| Glimepiride 1mg + Metformin 500 mg | 10 X 10 tablets | ZYVANA M1 |
| Glimepiride 2mg + Metformin 500mg | 10 X 10 tablets | ZYVANA M2 |
| Glimepiride 1mg + Metformin 1000mg | 10 X 10 tablets | ZYVANA M1 FORTE |
| Glimepiride 2mg + Metformin 1000mg | 10 X 10 tablets | ZYVANA M2 FORTE |
Generic Name: METFORMIN HYDROCHLORIDE
Description : Metformin decreases hepaticglucose production, decreases intestinal absorption of glucose, and improves insulin sensitivity by increasing peripheral glucose uptake and utilization.
Metformin improves glucose tolerance in patients with type 2 diabetes, lowering both basal and postprandial plasmaglucose.
Indications: IAs an adjunct to diet and exercise to improve glycemic control in adults with type 2 Diabetes mellitus.
Patient guidance: Patients with diabetes should be advised to inform their healthcare provider if they are pregnant, contemplating pregnancy, breastfeeding, or contemplating breastfeeding.
Storage: Store at 25° C (77° F)
| Strengths Available | Presentation | Brand Name |
| Metformin sustained release 500mg | 10 X 10 tablets | CONFIRMIN 500 mg |
| Metformin sustained release 1000mg | 10 X 10 tablets | CONFIRMIN 1000 mg |